The New R&D Tax Credit: Many Life Sciences Companies Are Leaving Money on the Table

Neil Shah and Jordan Jahrling of Alliantgroup are featured in our new video, The New R&D Tax Credit: Many Life Sciences Companies Are Leaving Money on the Table. The video captures highlights from an in-depth webinar made possible by Berkley Life Sciences.

Recent changes under the so-called “Big Beautiful Bill” have significantly reshaped the R&D tax credit landscape. In many cases, the credit has expanded—yet many life sciences companies continue to underclaim benefits available to them. At the same time, increased IRS scrutiny has raised the bar on documentation and compliance.

Drawing on their experience helping companies secure hundreds of millions of dollars in credits, Shah and Jahrling outline what qualifies as R&D today, where organizations commonly fall short, and how leaders can prepare for audits while still maximizing incentives. The video offers timely, practical guidance for pharmaceutical, biotechnology, and medical device executives navigating a more complex—but potentially more rewarding—R&D tax environment.

Watch the video here.

About The Vanguard Network

The Vanguard Network is a leadership community and advisory platform that helps senior executives sharpen foresight, strengthen performance, and achieve impact. Through forums, exchanges, and programs, Vanguard convenes leaders across industries to share challenges and solutions in a confidential, collaborative setting.